REFERENCE
Amadeus Investigators.Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial. Lancet 371: 315-321, No. 9609, 26 Jan 2008
Rights and permissions
About this article
Cite this article
Increased haemorrhage risk with idraparinux leads to trial termination. React. Wkly. 1187, 1 (2008). https://doi.org/10.2165/00128415-200811870-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200811870-00001